Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Pfizer Inc has a consensus price target of $39.14 based on the ratings of 22 analysts. The high is $60 issued by Goldman Sachs on December 13, 2022. The low is $29 issued by Morgan Stanley on May 2, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Cantor Fitzgerald, and Bernstein on October 25, 2024, October 23, 2024, and October 17, 2024, respectively. With an average price target of $40.67 between Cantor Fitzgerald, Cantor Fitzgerald, and Bernstein, there's an implied 43.50% upside for Pfizer Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Pfizer (NYSE:PFE) was reported by Cantor Fitzgerald on October 25, 2024. The analyst firm set a price target for $45.00 expecting PFE to rise to within 12 months (a possible 58.67% upside). 38 analyst firms have reported ratings in the last year.
The latest analyst rating for Pfizer (NYSE:PFE) was provided by Cantor Fitzgerald, and Pfizer reiterated their overweight rating.
The last upgrade for Pfizer Inc happened on August 8, 2024 when Daiwa Capital raised their price target to $34. Daiwa Capital previously had a neutral for Pfizer Inc.
The last downgrade for Pfizer Inc happened on March 22, 2024 when Argus Research changed their price target from N/A to N/A for Pfizer Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pfizer, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pfizer was filed on October 25, 2024 so you should expect the next rating to be made available sometime around October 25, 2025.
While ratings are subjective and will change, the latest Pfizer (PFE) rating was a reiterated with a price target of $45.00 to $45.00. The current price Pfizer (PFE) is trading at is $28.36, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.